Biotech company developing new selective and potent drugs targeting intrinsically disordered proteins to address unmet medical needs.
The company’s mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications. Nuage Therapeutics is a spin-off from IRB Barcelona and ICREA located in the Barcelona Science Park (PCB).
